This video reviews the need for biomarkers and tools that could identify those at high risk of immune-related toxicities among patients undergoing immunotherapy treatment.
In this video, Vamsidhar Velcheti, MD, of the Cleveland Clinic in Cleveland, Ohio, discusses the need for tools and biomarkers to identify those at high risk of immune-related toxicities among patients undergoing immunotherapy treatment, and reviews some of the dangerous toxicities that can occur.
Velcheti gave a presentation on this topic earlier this year during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
